MedTrace Logo

Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis

NCT05217485 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2022-02-01

No results posted yet for this study

Summary

To detect atrial fibrillation after infection.

Conditions

Interventions

DEVICE

Zio 14-day cardiac patch

A wearble adhesive cardiac patch (14-day) called Zio

Sponsors & Collaborators

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2023-03-31
Completion
2024-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05217485 on ClinicalTrials.gov